智通财经APP获悉科笛-B(02487)此前股价持续阴跌，今日盘中反弹近30%。截至发稿，涨22.03%，报4.93港元，成交额1.96亿港元，总市值仍不足16亿港元。
开源证券此前指出，科笛在研管线整体进展顺利，外用4%米诺环素泡沫剂（痤疮）、外用非那雄胺喷雾剂（脱发）、利多卡因丁卡因局麻膏三款重磅产品上市申请均已获受理，有望于2024下半年至2025年间陆续获批上市，进一步打开公司成长空间。
值得注意的是，恒生指数公司将在2025年2月21日公布恒生指数半年度审议结果，涉及恒生、国企、恒生科技等港股主要旗舰指数，以及与港股通投资范围密切相关的恒生综指。此后，沪深交易所将依此调整沪深港通投资标的范围。市场担忧公司遭剔出港股通名单。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.